| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 27,638 | 22,603 | 18,061 | 25,618 | | Cost of Revenue | 18,212 | 16,642 | 13,424 | 18,200 | | | Gross Profit | 9,426 | 5,961 | 4,637 | 7,418 | | | Operating Expenses | | Research Development | 7,441 | 7,455 | 11,740 | 7,889 | | Selling General and Administrative | 6,839 | 11,971 | 8,713 | 12,224 | | Non Recurring | 4,516 | (4,516) | 5,861 | 17,396 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,370) | (8,949) | (21,677) | (30,091) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (342) | 342 | (900) | (1,001) | | Earnings Before Interest And Taxes | (9,013) | (8,607) | (22,577) | (31,092) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,013) | (8,607) | (22,577) | (31,092) | | Income Tax Expense | (2,893) | (3,077) | (7,652) | (1,834) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,120) | (5,530) | (14,925) | (29,258) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,120) | (5,530) | (14,925) | (29,258) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,120) | ($5,530) | ($14,925) | ($29,258) |
|
0.32% Nasdaq 
0.26%
Income Statement
